| First Author | van Asselt SJ | Year | 2013 |
| Journal | Cilia | Volume | 2 |
| Issue | 1 | Pages | 3 |
| PubMed ID | 23384121 | Mgi Jnum | J:196611 |
| Mgi Id | MGI:5488860 | Doi | 10.1186/2046-2530-2-3 |
| Citation | van Asselt SJ, et al. (2013) Pancreatic cyst development: insights from von Hippel-Lindau disease. Cilia 2(1):3 |
| abstractText | Pancreatic cysts are a heterogeneous group of lesions, which can be benign or malignant. Due to improved imaging techniques, physicians are more often confronted with pancreatic cysts. Little is known about the origin of pancreatic cysts in general. Von Hippel-Lindau (VHL) disease is an atypical ciliopathy and inherited tumor syndrome, caused by a mutation in the VHL tumor suppressor gene encoding the VHL protein (pVHL). VHL patients are prone to develop cysts and neuroendocrine tumors in the pancreas in addition to several other benign and malignant neoplasms. Remarkably, pancreatic cysts occur in approximately 70% of VHL patients, making it the only hereditary tumor syndrome with such a discernible expression of pancreatic cysts. Cellular loss of pVHL due to biallelic mutation can model pancreatic cystogenesis in other organisms, suggesting a causal relationship. Here, we give a comprehensive overview of various pVHL functions, focusing on those that can potentially explain pancreatic cyst development in VHL disease. Based on preclinical studies, cilia loss in ductal cells is probably an important early event in pancreatic cyst development. |
